2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   7

Issue No. :  1

Year :  2014

Pages :   104-109

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

The Scene of Banned Drugs in India



Address:   Sunita Panchawat1* and Nupoor Sharma2
1Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur (Raj.)
2B. N. Institute of Pharmaceutical Sciences, Udaipur (Raj.)
*Corresponding Author
DOI No: Not Available

ABSTRACT:
India is becoming a hub for the availability and usage of banned/harmful medicines like Nimesulide, D’cold, Novalgin, Lomofen, Rofecoxib etc. A drug is banned on the basis of risk versus benefit ratio evaluated through post marketing surveillance and Adverse Drug Reaction Reporting System. Pharmaceutical negligence among doctors can lead to hazardous effects on the general health of a patient. The present study was planned to explore about awareness of banned drugs among educated youth and people related to this profession. Government should spread the information of drugs side effect. Doctors should not prescribe these drugs to protect the human health.
KEYWORDS:
Banned Drugs, Phenylpropanolamine, Novalgin, Sulfadoxin, Antimalarial etc.
Cite:
Sunita Panchawat, Nupoor Sharma. The Scene of Banned Drugs in India. Research J. Pharm. and Tech. 7(1): Jan. 2014; Page 104-109.
[View HTML]      [View PDF]



Visitor's No. :   642132